diagnostics

Opinions+ By Lâle White

What’s next for diagnostic labs, a ‘bright spot’ during Covid-19?

Health By Marion Renault

Could a souped-up version of existing Covid-19 tests be our shortcut to tracking variants?

Health Tech By Casey Ross

Amazon established a foothold in diagnostics during Covid-19. Now it’s doubling down

First Opinion By Walter Isaacson

CRISPR rivals put patents aside to help in fight against Covid-19

First Opinion By David Carr and H. Gilbert Welch

Editor’s note: This opinion piece is now outdated

Health By Elizabeth Cooney

‘A natural experiment’: Pandemic-driven drop in cancer screening may aid research on overdiagnosis

Biotech By Kate Sheridan

3 biotech trends to watch in 2021

Health By Associated Press

FDA allows first rapid coronavirus test that gives results at home

Biotech By Kate Sheridan

Exact Sciences acquires liquid biopsy company Thrive for $2.15 billion

In the Lab By Andrew Joseph

The CRISPR story: How a basic research discovery changed science and led to a Nobel

First Opinion By Edward Abrahams

Personalized medicine is the future of health care. Two Trump administration proposals could stymie it

Biotech By Kate Sheridan

Liquid biopsy startup Grail, in filing for IPO, lays out investments and plans for growth

Health By Kate Sheridan

U.S. needs 193 million Covid-19 tests per month to reopen schools and keep up with pandemic, new report says

Biotech By Elizabeth Cooney

Foundation Medicine wins FDA approval for liquid biopsy able to detect mutations in multiple cancers 

First Opinion By Jeffrey L. Schnipper and Paul E. Sax

Even Covid-19 tests that aren’t perfect can help control the pandemic

Health By Kate Sheridan

This tiny Texas company is running most of the drive-thru Covid-19 testing in the U.S.

Health By Kate Sheridan

Ginkgo Bioworks, Mammoth Biosciences among winners of NIH’s ‘Shark Tank’ for Covid-19 tests 

Pharmalot By Ed Silverman

Cepheid is accused of overcharging and undersupplying its Covid-19 test to poor countries

In the Lab By Elizabeth Cooney

A test you can breathe in: Scientists are developing synthetic biosensors to monitor lung disease

Politics By Matthew Herper

U.S. must spend $75 billion to fix flawed Covid-19 testing, report says

In the Lab By Juliet Isselbacher

Scientists create a speedy finger-prick test to scan for radiation exposure in mice

First Opinion By Anna Mehrotra, David A. Larsen, and Ashish K. Jha

It’s time to begin a national wastewater testing program for Covid-19

First Opinion By Prabhavathi Fernandes and Steve Brozak

Lack of rapid diagnostic tools contributes to Covid-19 deaths

Health By Erin Brodwin

Experts decry FDA’s halting of a high-profile Covid-19 study over approvals

Health Tech By Rebecca Robbins

AI systems are worse at diagnosing disease when training data is skewed by sex